Newsroom

RhythMedix Launches Next-Generation RhythmStar® Device, the First and Only Wearable Cardiac Monitor with Built-In Cellular Connectivity

MOUNT LAUREL, NJ – February 18, 2021, – RhythMedix, a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar® wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is discreetly worn for extended remote monitoring without the need for an additional phone or c...
Read More

Visit us at HRS 2019, Booth 2228

Are you going to HRS, May 8th-11th in San Francisco? If so, stop by the RhythMedix booth to say hello and see the latest updates on the RhythmStar Cardiac Monitoring System.

ISO 13485:2016 Certification Announcement

On June 5, 2018 Perry Johnson Registrars certified RhythMedix’s compliance to ISO 13485:2016 Medical devices quality management systems for design, manufacture, selling, and support of its cardiac monitoring devices and systems for use within the healthcare and medical Industry. International Standards Organization (ISO) is a worldwide federation...
Read More

RhythMedix Monitoring Center Receives Joint Commission’s Gold Seal of Approval

MOUNT LAUREL, NJ – September 29, 2017, – RhythMedix, today announced it has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation for the RhythMedix Cardiac Monitoring Center. The rigorous accreditation process symbolizes RhythMedix’s deep commitment to providing safe and effective patient ca...
Read More

RhythMedix’ RhythmStar System for arrhythmia monitors over 23,000 patients

The RhythmStar Remote Cardiac Monitoring System functions in three monitoring modes, Holter, which records a patient’s heart rhythm for one to two days; Event, worn for 30 days by patients who have infrequent cases of arrhythmia; and Mobile Cardiac Telemetry (MCT), which provides real-time monitoring and analysis by a registered nurse.
Read More

RhythMedix® exceeds first year projections; monitors over 23,000 patients on innovative RhythmStar® Remote Cardiac Monitoring System

RhythMedix today announced that over 23,000 patients at sites across the U.S. have used the RhythmStar System after market entry in March 2015. To support commercialization, the company has undergone a rigorous non-infringement patent assessment process and secured a multi-million-dollar litigation patent defense insurance policy from Intellectual ...
Read More

RhythMedix Announces its Monitoring Center approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF)